ASSESSMENT OF RISK FOR GASTROINTESTINAL AND CARDIOVASCULAR COMPLICATIONS ASSOCIATED WITH THE USE OF NONSTEROIDAL ANTI-INFLAMMATORY DRUGS IN THE CIS POPULATION: PRELIMINARY DATA OF THE CORONA-2 EPIDEMIOLOGICAL SURVEY
Nonsteroidal anti-inflammatory drugs (NSAIDs) are able to effectively control the major symptoms of rheumatic diseases and widely used in real clinical practice. However, they may cause serious gastrointestinal (GI) and cardiovascular (CV) events. The prevention of these events is based on the estim...
Saved in:
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
IMA PRESS LLC
2014-12-01
|
| Series: | Научно-практическая ревматология |
| Subjects: | |
| Online Access: | https://rsp.mediar-press.net/rsp/article/view/2004 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849240205119193088 |
|---|---|
| author | A. E. Karateev T. V. Popkova D. S. Novikova E. L. Nasonov G. A. Togizbaev N. A. Martusevich A. A. Aroyan M. Z. Rizamukhamedova |
| author_facet | A. E. Karateev T. V. Popkova D. S. Novikova E. L. Nasonov G. A. Togizbaev N. A. Martusevich A. A. Aroyan M. Z. Rizamukhamedova |
| author_sort | A. E. Karateev |
| collection | DOAJ |
| description | Nonsteroidal anti-inflammatory drugs (NSAIDs) are able to effectively control the major symptoms of rheumatic diseases and widely used in real clinical practice. However, they may cause serious gastrointestinal (GI) and cardiovascular (CV) events. The prevention of these events is based on the estimation of whether risk factors (RFs) are present.Objective: to estimate the presence of RFs in patients needing NSAIDs.Subjects and methods. A cross-sectional epidemiological survey was performed, during which 2021 physicians from 9 CIS countries questioned for 2 weeks at least 10 patients needing NSAIDs. The inclusion criterion was severe musculoskeletal pain (>40 mm on a 100-mm visual analogue scale (VAS)) or use of NSAIDs at the examination. Data were obtained on 21,185 patients (57.5% women and 42.5% men) (mean age 50.5±14.1 years) who had predominantly dorsalgia (56.6%) and osteoarthritis (23.5%). The mean pain value was 62.2±25.2 mm.Results. 1.7, 11.3, and 25.3% of patients had history of gastrointestinal bleeding, ulcer, or dyspepsia, respectively; people over 65 years of age constituted 16.8%; those who took low-dose aspirin (LDA) – 20.0%. The total number of patients at high risk for GI events was 29.0%. There were also common CV RFs: myocardial infarction or stroke (7.8%), coronary heart disease (17.8%), hypertension (37.7%), and diabetes mellitus (8.1%). The total number of patients at high risk for CV events (without SCOR assessment) was 23.0%. Many high-risk patients who has already used NSAIDs received no effective prevention. Thus, 62.2% of the patients at high GI risk took gastroprotective drugs; 53.2% of those at high CV risk used LDA.Conclusion. A large number of patients needing active analgesic therapy have a serious risk for drug-induced complications. This limits the possibility of using NSAIDs and determines the need for effective prevention or use of alternative methods for analgesia. |
| format | Article |
| id | doaj-art-39bc5cd68d004627b362a221e4f472c7 |
| institution | Kabale University |
| issn | 1995-4484 1995-4492 |
| language | Russian |
| publishDate | 2014-12-01 |
| publisher | IMA PRESS LLC |
| record_format | Article |
| series | Научно-практическая ревматология |
| spelling | doaj-art-39bc5cd68d004627b362a221e4f472c72025-08-20T04:00:41ZrusIMA PRESS LLCНаучно-практическая ревматология1995-44841995-44922014-12-0152660060610.14412/1995-4484-2014-600-6061923ASSESSMENT OF RISK FOR GASTROINTESTINAL AND CARDIOVASCULAR COMPLICATIONS ASSOCIATED WITH THE USE OF NONSTEROIDAL ANTI-INFLAMMATORY DRUGS IN THE CIS POPULATION: PRELIMINARY DATA OF THE CORONA-2 EPIDEMIOLOGICAL SURVEYA. E. Karateev0T. V. Popkova1D. S. Novikova2E. L. Nasonov3G. A. Togizbaev4N. A. Martusevich5A. A. Aroyan6M. Z. Rizamukhamedova7V.A. Nasonova Research Institute of Rheumatology, Moscow, RussiaV.A. Nasonova Research Institute of Rheumatology, Moscow, RussiaV.A. Nasonova Research Institute of Rheumatology, Moscow, RussiaV.A. Nasonova Research Institute of Rheumatology, Moscow, RussiaInstitute of Joint Diseases, Almaty, Republic of KazakhstanBelorussian State Medical University, Minsk, Republic of BelarusErebuni Medical Center, Erevan, Republic of ArmeniaTashkent Medical Academy, Tashkent, UzbekistanNonsteroidal anti-inflammatory drugs (NSAIDs) are able to effectively control the major symptoms of rheumatic diseases and widely used in real clinical practice. However, they may cause serious gastrointestinal (GI) and cardiovascular (CV) events. The prevention of these events is based on the estimation of whether risk factors (RFs) are present.Objective: to estimate the presence of RFs in patients needing NSAIDs.Subjects and methods. A cross-sectional epidemiological survey was performed, during which 2021 physicians from 9 CIS countries questioned for 2 weeks at least 10 patients needing NSAIDs. The inclusion criterion was severe musculoskeletal pain (>40 mm on a 100-mm visual analogue scale (VAS)) or use of NSAIDs at the examination. Data were obtained on 21,185 patients (57.5% women and 42.5% men) (mean age 50.5±14.1 years) who had predominantly dorsalgia (56.6%) and osteoarthritis (23.5%). The mean pain value was 62.2±25.2 mm.Results. 1.7, 11.3, and 25.3% of patients had history of gastrointestinal bleeding, ulcer, or dyspepsia, respectively; people over 65 years of age constituted 16.8%; those who took low-dose aspirin (LDA) – 20.0%. The total number of patients at high risk for GI events was 29.0%. There were also common CV RFs: myocardial infarction or stroke (7.8%), coronary heart disease (17.8%), hypertension (37.7%), and diabetes mellitus (8.1%). The total number of patients at high risk for CV events (without SCOR assessment) was 23.0%. Many high-risk patients who has already used NSAIDs received no effective prevention. Thus, 62.2% of the patients at high GI risk took gastroprotective drugs; 53.2% of those at high CV risk used LDA.Conclusion. A large number of patients needing active analgesic therapy have a serious risk for drug-induced complications. This limits the possibility of using NSAIDs and determines the need for effective prevention or use of alternative methods for analgesia.https://rsp.mediar-press.net/rsp/article/view/2004nonsteroidal anti-inflammatory drugsgastrointestinal riskcardiovascular riskprevention. |
| spellingShingle | A. E. Karateev T. V. Popkova D. S. Novikova E. L. Nasonov G. A. Togizbaev N. A. Martusevich A. A. Aroyan M. Z. Rizamukhamedova ASSESSMENT OF RISK FOR GASTROINTESTINAL AND CARDIOVASCULAR COMPLICATIONS ASSOCIATED WITH THE USE OF NONSTEROIDAL ANTI-INFLAMMATORY DRUGS IN THE CIS POPULATION: PRELIMINARY DATA OF THE CORONA-2 EPIDEMIOLOGICAL SURVEY Научно-практическая ревматология nonsteroidal anti-inflammatory drugs gastrointestinal risk cardiovascular risk prevention. |
| title | ASSESSMENT OF RISK FOR GASTROINTESTINAL AND CARDIOVASCULAR COMPLICATIONS ASSOCIATED WITH THE USE OF NONSTEROIDAL ANTI-INFLAMMATORY DRUGS IN THE CIS POPULATION: PRELIMINARY DATA OF THE CORONA-2 EPIDEMIOLOGICAL SURVEY |
| title_full | ASSESSMENT OF RISK FOR GASTROINTESTINAL AND CARDIOVASCULAR COMPLICATIONS ASSOCIATED WITH THE USE OF NONSTEROIDAL ANTI-INFLAMMATORY DRUGS IN THE CIS POPULATION: PRELIMINARY DATA OF THE CORONA-2 EPIDEMIOLOGICAL SURVEY |
| title_fullStr | ASSESSMENT OF RISK FOR GASTROINTESTINAL AND CARDIOVASCULAR COMPLICATIONS ASSOCIATED WITH THE USE OF NONSTEROIDAL ANTI-INFLAMMATORY DRUGS IN THE CIS POPULATION: PRELIMINARY DATA OF THE CORONA-2 EPIDEMIOLOGICAL SURVEY |
| title_full_unstemmed | ASSESSMENT OF RISK FOR GASTROINTESTINAL AND CARDIOVASCULAR COMPLICATIONS ASSOCIATED WITH THE USE OF NONSTEROIDAL ANTI-INFLAMMATORY DRUGS IN THE CIS POPULATION: PRELIMINARY DATA OF THE CORONA-2 EPIDEMIOLOGICAL SURVEY |
| title_short | ASSESSMENT OF RISK FOR GASTROINTESTINAL AND CARDIOVASCULAR COMPLICATIONS ASSOCIATED WITH THE USE OF NONSTEROIDAL ANTI-INFLAMMATORY DRUGS IN THE CIS POPULATION: PRELIMINARY DATA OF THE CORONA-2 EPIDEMIOLOGICAL SURVEY |
| title_sort | assessment of risk for gastrointestinal and cardiovascular complications associated with the use of nonsteroidal anti inflammatory drugs in the cis population preliminary data of the corona 2 epidemiological survey |
| topic | nonsteroidal anti-inflammatory drugs gastrointestinal risk cardiovascular risk prevention. |
| url | https://rsp.mediar-press.net/rsp/article/view/2004 |
| work_keys_str_mv | AT aekarateev assessmentofriskforgastrointestinalandcardiovascularcomplicationsassociatedwiththeuseofnonsteroidalantiinflammatorydrugsinthecispopulationpreliminarydataofthecorona2epidemiologicalsurvey AT tvpopkova assessmentofriskforgastrointestinalandcardiovascularcomplicationsassociatedwiththeuseofnonsteroidalantiinflammatorydrugsinthecispopulationpreliminarydataofthecorona2epidemiologicalsurvey AT dsnovikova assessmentofriskforgastrointestinalandcardiovascularcomplicationsassociatedwiththeuseofnonsteroidalantiinflammatorydrugsinthecispopulationpreliminarydataofthecorona2epidemiologicalsurvey AT elnasonov assessmentofriskforgastrointestinalandcardiovascularcomplicationsassociatedwiththeuseofnonsteroidalantiinflammatorydrugsinthecispopulationpreliminarydataofthecorona2epidemiologicalsurvey AT gatogizbaev assessmentofriskforgastrointestinalandcardiovascularcomplicationsassociatedwiththeuseofnonsteroidalantiinflammatorydrugsinthecispopulationpreliminarydataofthecorona2epidemiologicalsurvey AT namartusevich assessmentofriskforgastrointestinalandcardiovascularcomplicationsassociatedwiththeuseofnonsteroidalantiinflammatorydrugsinthecispopulationpreliminarydataofthecorona2epidemiologicalsurvey AT aaaroyan assessmentofriskforgastrointestinalandcardiovascularcomplicationsassociatedwiththeuseofnonsteroidalantiinflammatorydrugsinthecispopulationpreliminarydataofthecorona2epidemiologicalsurvey AT mzrizamukhamedova assessmentofriskforgastrointestinalandcardiovascularcomplicationsassociatedwiththeuseofnonsteroidalantiinflammatorydrugsinthecispopulationpreliminarydataofthecorona2epidemiologicalsurvey |